dr. bendell on the future of regorafenib for patients with crc
Published 6 years ago • 173 plays • Length 0:42Download video MP4
Download video MP3
Similar videos
-
1:08
dr. bendell on fda approval of regorafenib in liver cancer
-
0:49
dr. bendell on remaining questions with regorafenib in hcc
-
16:35
dr. finn on regorafenib for the treatment for patients with hcc
-
5:31
practical advice for using regorafenib
-
11:24
managing toxicities associated with regorafenib
-
1:07
dr. bendell on the next steps following progression on immunotherapy in msi-h crc
-
2:13
dr. lenz on the benefit of regorafenib in crc
-
0:42
dr. keedy on regorafenib for the treatment of gist
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
9:34
regorafenib in colorectal cancer
-
0:57
dr. bekaii-saab discusses the next steps with regorafenib in crc
-
3:54
colorectal cancer: patient follow-up with regorafenib
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
6:33
patient selection for regorafenib in crc
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
1:23
dr. george demetri discusses regorafenib for patients with gist trial results
-
1:47
dr. jordi bruix on the impact regorafenib will have on liver cancer treatment
-
24:26
dr. van cutsem on regorafenib for patients with colorectal cancer